Abstract
Descriptive epidemiology of Parkinson’s disease (PD), by providing a profile of the disease, should be useful in the etiological investigation of PD. Etiological hypotheses need to be consistent with known epidemiologic factors, and descriptive epidemiologic observations may generate a new hypothesis. Analytic epidemiology seeks to identify risk factors that could lead to clues for causal associations with the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aquilonius SM, Hartvig P (1986): A Swedish county with unexpectedly high utilization of anti-parkinsonian drugs. Acta Neurol Scand74:379
Ashok PP, Radhakrishnan K, Sridharan R, Mousa ME (1986): Epidemiology of Parkinson’s disease in Benghazi, north-east Libya. Neurosurgery88(2): 109–113
Bademosi O, Al-Rajeh IH, Awada A (1991): Prevalence of Parkinson’s disease (PD) in an Arab community: the Thugbah study. In: Congres de neurologie tropicale, September 26–28, 1991, p. 27. Recherche en Neurologic Tropicale Press
Barbeau A, Roy M (1985): Uneven prevalence of Parkinson’s disease in the province of Quebec. Can J Neurol Sci12:169–170
Barbeau A, Roy M, Bernier G, et al. (1987): Ecogenetics of Parkinson’s disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci14:36–41
Baumann RJ, Jamesson HD, McKean HE, Haack DG, Weisburg LM (1980): Cigarette smoking and Parkinson’s disease. I. A comparison of cases with matched neighbors. Neurology30:839
Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS (1988): Prevalence of Parkinson’s disease in the Parsi community in Bombay, India. Arch Neurol45:1321–1323
Bodmer WF (1973): Population genetics of the HLA system: retrospect and prospect. In: Histocompatibility Testing 1972, Dausset J, Colombani J, eds., pp. 611–667. Copenhagen: Munksgaard
Brewis M, Poskanzer DC, Rolland C, Miller H (1966): Neurological disease in an English city. Acta Neurol Scand42(Suppl 24): 1–89
Broman T (1963): Parkinson’s syndrome, prevalence and incidence in Goteborg. Acta Neurol Scand51 (Suppl 4):95–101
Burch PRJ (1981): Cigarette smoking and Parkinson’s disease. Neurology31:500.
Burns SP, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983): A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA80:4546–4550
Calne DB, Langston JW (1983): Aetiology of Parkinson’s disease. Lancet2:1457–1459
Casetta I, Granieri E, Govoni V, et al. (1990): Epidemiology of Parkinson’s disease in Italy. A descriptive survey in the U.S.L. of Cento, province of Ferrara, Emilia-Romagna. Acta Neurol(Napoli) 12:284–291
Clifford WB, Heaton TB, Voss PR, Fuguitt GV (1985): The rural elderly in demographic perspective. In: The Elderly in Rural Society: Every Fourth Elder, Coward RT, Lee GR, eds., pp. 25–55. New York: Springer
D’Alessandro R, Gamberini G, Granieri E, Benassi G, Naccarato S, Manzaroli D (1987): Prevalence of Parkinson’s disease in the Republic of San Marino. Neurology37:1679–1682
Dupont E (1977): Epidemiology of parkinsonism. The Parkinson investigation, Arhus, Denmark (preliminary results). In: Symposium on Parkinsonism, Worm-Peterson J, Bottcher J, eds., pp. 65–75. Denmark: Merck, Sharp & Dohme
Golbe LI, Farrell T (1988): Case-control survey of early-adult dietary habits in Parkinson’s disease. Neurology38(Suppl 1):204
Granieri E, Carreras M, Casetta I, et al. (1991): Parkinson’s disease in Ferrara, Italy, 1967 through 1987. Arch Neurol48:854–857
Gudmundsson KR (1967): A clinical survey of parkinsonism in Iceland. Acta Neurol Scand43(Suppl) 33:1–61
Harado H, Nishikawa S, Takahashi K (1983): Epidemiology of Parkinson’s disease in a Japanese city. Arch Neurol40:151–154
Ho SC, Woo J, See CM (1989): Epidemiologic study of Parkinson’s disease in Hong Kong. Neurology39:1314–1318
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992): The accuracy of the clinical diagnosis of Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry55:181–184
Jannson B, Jankovic J (1985): Low cancer rates among patients with Parkinson’s disease. Ann Neurol17:505
Jenkins AC (1966): Epidemiology of parkinsonism in Victoria. Med J Aust2:496–502
Jenner P, Marsden CD (1988): MPTP-induced parkinsonism in primates and its use in the assessment of novel strategies for the treatment of Parkinson’s disease. In: Current Problems in Neurology (6): Parkinson’s Disease: Clinical and Experimental Advances, Rose FC, ed., pp. 149–162. London: John Libbey
Jimenez-Jimenez FJ, Gonzales DM, Gimrnez-Roldan S (1988): Exposure to well water drinking and pesticides in Parkinson’s disease. In: Proceedings of the Ninth International Symposium on Parkinson’s Disease, p. 118, World Congress of Neurology, Jerusalem
Kessler II (1972): Epidemiologic studies of Parkinson’s disease. A hospital-based survey. Am J Epidemiol95:308–318
Kessler II (1973): Parkinson’s disease: perspectives on epidemiology and pathogenesis. Prev Med2:88–105
Koller WC (1983): Alcoholism in essential tremor. Neurology33:1074
Koller WC (1992): When does Parkinson’s disease begin? Neurology43(Suppl 4):27–31
Koller WC, Vetere-Overfield B, Gray C, Alexander C, Chin T, Dolezal, Hassanein R, Tanner C (1990): Environmental risk factors in Parkinson’s disease. Neurology40: 1218–1221
Kurland LT (1958): Epidemiology: incidence, geographic distribution and genetic considerations. In: Pathogenesis and Treatment of Parkinsonism, Field WS, ed., pp. 5–49. Springfield, IL: Charles C. Thomas
Kurtzke JF, Murphy FM (1990): The changing patterns of death rates in parkinsonism. Neurology40:42–49
Langston JW, Langston EB, Irwin I (1984a): MPTP-induced parkinsonism in human and non-human primates. Clinical and experimental aspects. Acta Neurol Scand70:49–54
Langston JW, Forno LS, Rebert CS, Irwin (1984b): Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res292:390–394
Li SC, Schoenberg BS, Wang CC, et al. (1985): A prevalence survey of Parkinson’s disease and other movement disorders in the People’s Republic of China. Arch Neurol42:655–657
Marmot M (1981): Mortality and Parkinson’s disease. In: Research Progress in Parkinson’s Disease 1980, Rose F, Capildeo R, eds. pp. 9–16. Kent: Tunbridge Wells
Marttila RJ, Rinne U (1976): Epidemiology of Parkinson’s disease in Finland. Acta Neurol Scand53:81–102
Meador KJ, Meador MP, Loring DS, et al. (1987): Neuroepidemiology of Parkinson’s disease. Neurology37(Suppl 1): 120
Mitchell IJ, Cross AJ, Sambrook MA, Crossman AR (1985): Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus. Neurosci Lett61:195–200
Morgante L, Racco WA, Rosa AE (1992): Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology42: 1901–1906
Nobrega FT, Glattre E, Kurland LT, Okazaki H (1969): Comments on the epidemiology of parkinsonism including prevalence and incidence statistics for Rochester, Minnesota, 1935–1936. In: Progress in Neuro-Genetics: Proceedings of the International Congress of Neuro-Genetics, Barbeau A, Brunette JS, eds., pp. 474–485. Amsterdam: Excerpta Medica
Okada K, Kobayashi S, Tsunematsu T (1990): Prevalence of Parkinson’s disease in Izumo City, Japan. Gerontology36:340–344
Rajput AH, Stern W, Christ A, Laverty W (1984a): Etiology of Parkinson’s disease: environmental factor(s). Neurology34(Suppl 1):207
Rajput AH, Offurd KP, Beard CM, Kurland LT (1984b): Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol16:278–282
Rajput AH, Offurd KP, Beard CM, Kurland LT (1984c): A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson’s disease. Neurology37:226
Rajput AH, Uitti RJ, Stern W, et al. (1987b): Geography, drinking water chemistry, pesticides, and herbicides and the etiology of Parkinson’s disease. Can J Neurol Sci14:414
Rajput AH, Uitti RJ, Stern W, et al. (1986): Early onset Parkinson’s disease in Saskatchewan: environmental considerations for etiology. Can J Neurol Sci13:212–216
Rosati G, Granieri E, Pinna L, et al. (1978): Parkinson’s disease. Prevalence and incidence in the province of Sassari, North Sardinia. Acta Neurol(Napoli) 33:210–207
Rosati G, Granieri E, Pinna L, Devoto MC (1979): The frequency of Parkinson’s disease in the province of Nuoro (Sardinia). Acta Neurol1:303–308
Rosati G, Granieri E, Pinna L, et al. (1980): The risk of Parkinson’s disease in Mediterranean people. Neurology30:250–255
Sasco AJ, Paffenberger RS, Jr (1985): Measles infection and Parkinson’s disease. Am J Epidemiol122:1017
Schoenberg BS, Anderson DW, Haerer AF (1985): Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology35:841–845
Schoenberg BS, Osuntokun BO, Adeuja AO, et al. (1988): Comparison of the prevalence of Parkinson’s disease in black populations in the rural United States and rural Nigeria: door-to-door community studies. Neurology38:645–646
Semchuck KM, Love EJ, Lee RG (1991): Parkinson’s disease and exposure to rural environmental factors: a population based case-control study. Can J Neurol Sci18:279–386
Snow B, Wiens M, Hertzman C, Calne DB (1989): A community survey of Parkinson’s disease. Can Med Assoc141:418–422
Spencer PS, Kisby GE, Ludopha AC (1991): Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region. Neurology41(Suppl 2):62–66
Steventon GB, Heafield MTE, Waring RH, Williams AC (1989): Xenobiotic metabolism in Parkinson’s disease. Neurology39:883–887
Tanner CM, Chen B, Wang WZ, et al. (1987): Environmental factors in the etiology of Parkinson’s disease. Can J Neurol Sci14:419
Tanner CM, Cohen JC, Summerville BC, Goetz CG (1988): Vitamin use and Parkinson’s disease. Ann Neurol233:182
Teräväinen H, Forgach L, Hietanen M, Schulzer M, Schoenberg BS, Calne DB (1986): The age of onset of Parkinson’s disease, etiologic implications. Can J Neurol Sci13:317
Tetrud JW, Langston JW (1987): L-Deprenyl as a possible protective agent in Parkinson’s disease. J Neural transm25:69–79
Wang Y, Shi Y, Wu S, He Y, Zhang B (1991): Parkinson’s disease in China. Chin Med J33:960–964
Waring RH, Sturman SG, Smith MCG, Steventon GB, Heafield MTE, Williams AC (1989): S-Methylation in motor neuron disease and Parkinson’s disease. Lancet2:356–357
Wender M, Pruchnik D, Kowal P, Florczak J, Zalejski M (1989): Epidemiology of Parkinson’s disease in the Pozna’n province. Przegl Epidemiol43:150–155
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Birkhäuser Boston
About this chapter
Cite this chapter
Koller, W.C. (1994). Neuroepidemiology of Parkinson’s Disease: Environmental Influences. In: Mizuno, Y., Calne, D.B., Horowski, R. (eds) Etiopathogenesis. Advances in Research on Neurodegeneration, vol 2. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4684-9203-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-9203-3_4
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4684-9205-7
Online ISBN: 978-1-4684-9203-3
eBook Packages: Springer Book Archive